Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-09-27 23:00:14 - browse：7219

Committee chairman Rep. Jason Smith (R-MO) speaks with ranking member Rep. Richard Neal (D-MA) during a House Ways and Means Committee hearing on Capitol Hill March 10, 2023 in Washington, DC. – health care policy coverage from STAT — Committee chairman Rep. Jason Smith (R-Mo.) speaks with ranking member Rep. Richard Neal (D-Mass.). Drew Angerer/Getty Images

WASHINGTON — It’s two weeks until Congress leaves town in August, and a prominent House panel is throwing a wrench in what seemed like a smooth path forward for legislation to require more transparency in health care prices, and to change Medicare drug payments.

The House Energy & Commerce Committee already introduced, held multiple hearings on, and unanimously passed out of committee a package of legislation including transparency requirements for hospitals and pharmacy benefit managers and a so-called “site-neutral” pay policy for drugs administered in doctors’ offices.

But leaders of the House Ways & Means Committee are planning to release their own health care legislation this month, complicating the chamber’s path to passing something soon, four lobbyists told STAT.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Johnson & Johnson sued for allegedly overpaying for workers' drugs

WSS

What’s missing from the debate over nursing home staff minimums

New safety details link Apellis eye drug to rare cases of blindness

EQRx, failed developer of low

Breakthrough Alzheimer’s drugs are inaccessible in rural states

Why Novartis is going to walk from its acquisition of MorphoSys

Problems with a popular proposal to regulate AI in health care

entertainment

Wikipedia

hotspot

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Devoted Health’s losses in Medicare Advantage persist

Medicare details structure of new drug price negotiation program

EQRx, failed developer of low

Medicare proposal to cover medical devices draws a mixed reaction

Why CTE doesn’t keep Americans from enjoying the Super Bowl

Tori Bowie and the unacceptable rates of Black maternal death

Sage hopes for a blockbuster in antidepressant now before FDA

Medical records are filled with copy

‘Oppenheimer’ and the risks of AI in health care

Wikipedia

The high personal cost of affirmative action for Black doctors

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

Cano Health’s bankruptcy is a warning for Medicare Advantage

A protest over insulin prices is seen as a fight for life

AI gets buy

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

leisure time

Wikipedia

knowledge

entertainment